Fundraising FoxWestlake Village BioPartners — 2025 Investments
6 investments dated 2025 · listed companies and verified rows first · show all
Arpeggio Bio develops pharmaceutical drugs that target transcription factors using artificial intelligence and RNA-sequencing technology, with lead programs in development for melanoma treatment and rare disease applications.
BiotechHealthtechBoulder, US
Joey Azofeifa(Founder)inLaura Norris(Executive Officer, Director)inTimothy Read(Executive Officer, Director)Eric Martin(Executive Officer)in
BoardAmit Mehta(Director)
Board seatDavid AllisonMira Chaurushiya· per SEC Form D
Co-investorsATEM Capital FundFifty YearsFundersClubTau VenturesvenBio PartnersY Combinator+9 more
Latigo Biotherapeutics is a clinical-stage biopharmaceutical company developing non-opioid pain medicines designed to stop pain transmission without addiction risk.
BiotechHealthtechMedical DevicesThousand Oaks, US
Nima Farzan(Executive Officer, Director)Tim Lugo(Executive Officer)Sean Harper Desmond Padhi(Founder)
BoardJim Tananbaum(Director)inDeborah Palestrant(Director)in
Board seatBeth Seidenberg· per SEC Form D
Co-investors5AM VenturesAccess BiotechnologyAscenta CapitalForesite CapitalKern Capital, LLCSanofi Ventures
Star Therapeutics develops treatments aimed at addressing real-world patient needs.
BiotechSouth San Francisco, US
Adam Rosenthal(Founder & CEO)inNancy Stagliano(Director)inMichelle Carpenter(Executive Officer)Sandip Panicker(Executive Officer)Scott Robertson(Executive Officer)inGary Patou(Executive Officer)in
Board seatBeth Seidenberg· per SEC Form D
Co-investorsFrazier Life SciencesOrbiMedRA CapitalSanofi VenturesSofinnova VenturesViking Global+11 more
AllRock Bio is a drug development company advancing novel therapies for pulmonary hypertension, interstitial lung diseases, and other fibrotic conditions.
BiotechNatick, US
Catherine Pearce(CEO & Founder)inDHSc(Founder)Justin R Thompson(Founder)in
Co-investorsVersant VenturesWestlake BioPartners
Electra Therapeutics develops antibody therapeutics targeting Signal Regulatory Protein (SIRP) for immunological diseases and cancer treatment.
BiotechHealthtechMedical DevicesSouth San Francisco, US
Adam Rosenthal(Co-founder and former CEO; Director)inQuehuong (Kathy) Dong, Pharm.D.(Executive Officer, Director)Kathy Dong(President, Chief Executive Officer and Director)in
BoardBeth Seidenberg, M.D.(Director)Thomas Geninatti, Ph.D.(Director)Carl Gordon, Ph.D.(Director)
Co-investorsHBM Healthcare InvestmentsHBM PartnersOrbiMedRA CapitalKleiner PerkinsNVIDIA
Qumis provides an AI platform built for insurance coverage attorneys and law firms that analyzes complex insurance policies and programs, producing cited, confidence-scored comparisons, checklists, opinions, and client-ready deliverables.
AI & Machine LearningInsurTechLegalTechChicago, US
Shivam Sinha(Executive Officer, Director)Dan Schuleman(Executive Officer, Director)
BoardBrian McLoughlin(Director)inNeenah Jain(Director)in
Co-investorsAlumni VenturesAmerican Family VenturesMTECH CAPITALArmory Square Ventures
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.